BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6424462)

  • 1. Efficacy and safety of high-dose intravenous immune globulin therapy for antibody deficiency syndromes.
    Sorensen RU; Polmar SH
    Am J Med; 1984 Mar; 76(3A):83-90. PubMed ID: 6424462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: clinical efficacy and attempts to individualize dosage.
    Schiff RI; Rudd C; Johnson R; Buckley RH
    Clin Immunol Immunopathol; 1984 Apr; 31(1):13-23. PubMed ID: 6421523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions in selected patients following intravenous infusions of gamma globulin.
    Day NK; Good RA; Wahn V
    Am J Med; 1984 Mar; 76(3A):25-32. PubMed ID: 6231860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualizing the dose of intravenous immune serum globulin for therapy of patients with primary humoral immunodeficiency.
    Schiff RI
    Vox Sang; 1985; 49 Suppl 1():15-24. PubMed ID: 2416124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of a monomeric, functionally intact intravenous IgG preparation in patients with primary immunodeficiency syndromes.
    Eibl MM; Cairns L; Rosen FS
    Clin Immunol Immunopathol; 1984 Apr; 31(1):151-60. PubMed ID: 6421524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune globulin (human) 10 % liquid: a review of its use in primary immunodeficiency disorders.
    McCormack PL
    BioDrugs; 2013 Aug; 27(4):393-400. PubMed ID: 23703447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases.
    Ochs HD; Fischer SH; Wedgwood RJ; Wara DW; Cowan MJ; Ammann AJ; Saxon A; Budinger MD; Allred RU; Rousell RH
    Am J Med; 1984 Mar; 76(3A):78-82. PubMed ID: 6424461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children.
    Warrier I; Lusher JM
    Am J Med; 1984 Mar; 76(3A):193-8. PubMed ID: 6424451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
    Paryani SG; Arvin AM; Koropchak CM; Wittek AE; Amylon MD; Dobkin MB; Budinger MD
    Am J Med; 1984 Mar; 76(3A):124-7. PubMed ID: 6324585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin therapy for antibody deficiency.
    Nolte MT; Pirofsky B; Gerritz GA; Golding B
    Clin Exp Immunol; 1979 May; 36(2):237-43. PubMed ID: 477026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term use of intravenous immune globulin in patients with primary immunodeficiency diseases: inadequacy of current dosage practices and approaches to the problem.
    Buckley RH
    J Clin Immunol; 1982 Apr; 2(2 Suppl):15S-21S. PubMed ID: 6806314
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous immune globulin therapy for antibody immunodeficiency.
    Savéry F
    Clin Ther; 1984; 7(1):69-72. PubMed ID: 6518465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immune globulin: dosage and administration.
    Wordell CJ
    Pharmacotherapy; 1987; 7(2):S27-30. PubMed ID: 3299297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of intravenous gamma globulin in multiple myeloma.
    Gordon DS; Hearn EB; Spira TJ; Reimer CB; Phillips DJ; Schable C
    Am J Med; 1984 Mar; 76(3A):111-6. PubMed ID: 6424442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults.
    Oral A; Nusbacher J; Hill JB; Lewis JH
    Am J Med; 1984 Mar; 76(3A):187-92. PubMed ID: 6424449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immune serum globulin in immunodeficiency.
    Cunningham-Rundles C
    Vox Sang; 1985; 49 Suppl 1():8-14. PubMed ID: 2416128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states.
    Montanaro A; Pirofsky B
    Am J Med; 1984 Mar; 76(3A):67-72. PubMed ID: 6424459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immune globulin: a cautionary note.
    Cross AS; Alving BM; Sadoff JC; Baldwin P; Terebelo H; Tang D
    Lancet; 1984 Apr; 1(8382):912. PubMed ID: 6143221
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial.
    Ammann AJ; Ashman RF; Buckley RH; Hardie WR; Krantmann HJ; Nelson J; Ochs H; Stiehm ER; Tiller T; Wara DW; Wedgwood R
    Clin Immunol Immunopathol; 1982 Jan; 22(1):60-7. PubMed ID: 6749355
    [No Abstract]   [Full Text] [Related]  

  • 20. [The pathogenesis of immune complexes and the clinical intravenous use of IgG and enzyme-treated IgG preparation].
    Sedlacek HH; Seiler FR
    Beitr Infusionther Klin Ernahr; 1982; 9():80-94. PubMed ID: 6216882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.